Peptimmune

Peptimmune is developing peptide therapeutics for the treatment of CNS and autoimmune diseases.

History:

Spun out from Genzyme in January 2002

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: